Home > Balance Sheet > AARTI PHARMALABS

AARTI PHARMALABS
Total Non-Current Liabilities

    Back to Balance Sheet
AARTI PHARMALABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹131 Cr₹85 Cr₹73 Cr-

What is the latest Total Non-Current Liabilities ratio of AARTI PHARMALABS ?

The latest Total Non-Current Liabilities ratio of AARTI PHARMALABS is ₹131 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹131 Cr
Mar2023₹85 Cr
Mar2022₹73 Cr
Mar2021-

How is Total Non-Current Liabilities of AARTI PHARMALABS Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹131 Cr
53.89
Mar2023 ₹85 Cr
16.71
Mar2022 ₹73 Cr
0
Mar2021 - -

Compare Total Non-Current Liabilities of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹6,719.8 Cr 9.1% 13.3% 45.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,363.0 Cr -2.8% -3.6% 10.8% Stock Analytics
DIVIS LABORATORIES ₹158,396.0 Cr -2.5% 1.5% 59.1% Stock Analytics
CIPLA ₹117,088.0 Cr -1.5% 0.2% 1.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,458.0 Cr -1.6% -9.2% -4.3% Stock Analytics
ZYDUS LIFESCIENCES ₹94,002.4 Cr -7.4% -5.1% 9.9% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

9.1%

13.3%

45.2%

SENSEX

-2.7%

-0.4%

6.4%


You may also like the below Video Courses